Notice of NCATS Withdrawal from Participation in PAR-18-689, Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Notice Number: NOT-TR-20-024

Key Dates
Release Date: April 21, 2020

Related Announcements
PAR-18-689 Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Issued by
National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to inform prospective applicants that, effective immediately, the National Center for Advancing Translational Sciences (NCATS) is no longer participating in PAR-18-689, Innovative Therapies and Tools for Screenable Disorders in Newborns (R01 - Clinical Trial Optional.

Inquiries

Please direct all inquiries to:

NCATS Referral Office
Email: ncatsreferral@mail.nih.gov